Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
葛陈胶囊治疗良性前列腺增生(浊瘀阻塞证)安全性和有效性的随机、双盲、剂量平行对照、多中心Ⅱ期临床试验
[Translation] A randomized, double-blind, dose-controlled, multicenter phase II clinical trial on the safety and efficacy of Gechen capsule in the treatment of benign prostatic hyperplasia (turbidity and stasis syndrome).
通过观察葛陈胶囊缩小前列腺的作用,以及改善下尿路症状及生活质量的作用,初步评价葛陈胶囊治疗良性前列腺增生(浊瘀阻塞证)的安全性和有效性,同时进行剂量探索,为下一步临床试验提供设计依据。
[Translation] By observing the effect of Gechen Capsule in shrinking the prostate, and improving lower urinary tract symptoms and quality of life, we preliminarily evaluated the safety and effectiveness of Gechen Capsule in treating benign prostatic hyperplasia (turbidity and stasis obstruction syndrome), and conducted dose exploration to provide a design basis for the next clinical trial.
100 Clinical Results associated with Hangzhou Fulian Biotechnology Co., Ltd.
0 Patents (Medical) associated with Hangzhou Fulian Biotechnology Co., Ltd.
100 Deals associated with Hangzhou Fulian Biotechnology Co., Ltd.
100 Translational Medicine associated with Hangzhou Fulian Biotechnology Co., Ltd.